Patients with Schizophrenia Do Not Demonstrate Worse Outcome After Sleeve Gastrectomy: a Short-Term Cohort Study

Overview

Journal Obes Surg

Date 2018 Nov 7

PMID 30397877

Citations 5

Authors

Rami Archid

Nicole Archid

Tobias Meile

Jonas Hoffmann

Julia Hilbert

Daniel Wulff

Martin Teufel

Michaela Muthig

Markus Quante

Alfred Konigsrainer

Jessica Lange

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of this study was to compare surgical and psychiatric outcome and weight loss in schizophrenia patients with mentally healthy patients after sleeve gastrectomy.

Materials And Methods: A cohort study design was selected, comprising patients with schizophrenia with mentally healthy patients who underwent sleeve gastrectomy and were adherent to a follow-up at least 12 months after surgery.

Results: Seven schizophrenia (5 male, 2 female) and 59 (12 male, 47 female) mentally healthy patients were included in this study. A laparoscopic sleeve gastrectomy was performed safely in all 66 patients. The calculated excess weight loss (%EWL) showed no significant differences in both groups and reached 51.68 ± 15.84% for schizophrenia group and 60.68 ± 19.95% for mentally healthy group at 24-month follow-up (p = 0.33). The decrease in the HbA1c levels within 2 years after sleeve gastrectomy was similar in both groups (p = 0.79, 0.88, 0.82, 0.73 for surgery time, time of 6-, 12-, and 24-month follow-up respectively). The psychiatric status of the patients of the schizophrenia group was stable in all cases and no exacerbation of psychiatric symptoms was observed during time of follow-up. Furthermore, an overall significant improvement of the self-estimated mood and satisfaction was observed in both groups (Manova: f = 1.26, p < 0.0001).

Conclusions: The results 2 years after sleeve gastrectomy in stable patients with schizophrenia and after an adequate psychological evaluation were encouraging and comparable to the outcome in mentally healthy patients.

Citing Articles

Outcomes of Bariatric Surgery in Patients with Schizophrenia.

Minambres I, Rubio-Herrera M, Nicolau J, Milad C, Morales M, Bueno M Nutrients. 2024; 16(15).

PMID: 39125367 PMC: 11313780. DOI: 10.3390/nu16152487.

Chronic psychiatric diagnoses increase emergency department utilization following bariatric surgery.

Samuels J, Carmichael H, Hazel K, Velopulos C, Rothchild K, Schoen J Surg Endosc. 2022; 37(3):2215-2223.

PMID: 35879568 DOI: 10.1007/s00464-022-09451-z.

Generalized Anxiety as a Risk Factor for Dysfunctional Eating Behavior after Obesity Surgery during the COVID-19 Pandemic.

Pfeiffer C, Schweda A, Schuren L, Niedergethmann M, Steinbach J, Rentrop V Int J Environ Res Public Health. 2021; 18(20).

PMID: 34682635 PMC: 8536045. DOI: 10.3390/ijerph182010890.

Impact of Resection Volume/Stapler Firings-Ratio on Perioperative Complications and Weight Loss After Laparoscopic Sleeve Gastrectomy.

Della Penna A, Lange J, Archid R, Hones F, Konigsrainer A, Quante M Obes Surg. 2020; 31(1):207-214.

PMID: 32728840 PMC: 7808967. DOI: 10.1007/s11695-020-04870-0.

Experiences of Weight-Loss Surgery in People With Serious Mental Illness: A Qualitative Study.

Every-Palmer S, Romans S, Stubbs R, Tomlinson A, Gandhi S, Huthwaite M Front Psychiatry. 2020; 11:419.

PMID: 32477191 PMC: 7236816. DOI: 10.3389/fpsyt.2020.00419.

References

Sjostrom L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden A . Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014; 311(22):2297-304. DOI: 10.1001/jama.2014.5988. View

Lawlor B, Rand C . Schizophrenia and gastric surgery for obesity. Am J Psychiatry. 1986; 143(10):1321. DOI: 10.1176/ajp.143.10.1321a. View

Powers P, Rosemurgy A, Boyd F, Perez A . Outcome of gastric restriction procedures: weight, psychiatric diagnoses, and satisfaction. Obes Surg. 1998; 7(6):471-7. DOI: 10.1381/096089297765555197. View

Fuchs H, Laughter V, Harnsberger C, Broderick R, Berducci M, DuCoin C . Patients with psychiatric comorbidity can safely undergo bariatric surgery with equivalent success. Surg Endosc. 2015; 30(1):251-8. DOI: 10.1007/s00464-015-4196-8. View

Yu W, De Hert M, Moons T, Claes S, Correll C, van Winkel R . CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia. J Clin Psychopharmacol. 2013; 33(2):186-92. DOI: 10.1097/JCP.0b013e318283925e. View

Dubovsky S, Haddenhorst A, Murphy J, LIECHTY R, Coyle D . A preliminary study of the relationship between preoperative depression and weight loss following surgery for morbid obesity. Int J Psychiatry Med. 1985; 15(2):185-96. DOI: 10.2190/68ab-9lm9-7q1n-b1pw. View

Steinmann W, Suttmoeller K, Chitima-Matsiga R, Nagam N, Suttmoeller N, Halstenson N . Bariatric surgery: 1-year weight loss outcomes in patients with bipolar and other psychiatric disorders. Obes Surg. 2011; 21(9):1323-9. DOI: 10.1007/s11695-011-0373-6. View

Shelby S, Labott S, Stout R . Bariatric surgery: a viable treatment option for patients with severe mental illness. Surg Obes Relat Dis. 2015; 11(6):1342-8. DOI: 10.1016/j.soard.2015.05.016. View

Kalarchian M, Marcus M, Levine M, Soulakova J, Courcoulas A, Wisinski M . Relationship of psychiatric disorders to 6-month outcomes after gastric bypass. Surg Obes Relat Dis. 2008; 4(4):544-9. PMC: 3506113. DOI: 10.1016/j.soard.2008.03.003. View

10.

Daumit G, Clark J, Steinwachs D, Graham C, Lehman A, Ford D . Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness. J Nerv Ment Dis. 2003; 191(12):799-805. DOI: 10.1097/01.nmd.0000100923.20188.2d. View

11.

Colton C, Manderscheid R . Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006; 3(2):A42. PMC: 1563985. View

12.

Nemeroff C . Dosing the antipsychotic medication olanzapine. J Clin Psychiatry. 1997; 58 Suppl 10:45-9. View

13.

Semanscin-Doerr D, Windover A, Ashton K, Heinberg L . Mood disorders in laparoscopic sleeve gastrectomy patients: does it affect early weight loss?. Surg Obes Relat Dis. 2010; 6(2):191-6. DOI: 10.1016/j.soard.2009.11.017. View

14.

Adams T, Arterburn D, Nathan D, Eckel R . Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications. Diabetes Care. 2016; 39(6):912-23. PMC: 5562446. DOI: 10.2337/dc16-0157. View

15.

Bauchowitz A, Gonder-Frederick L, Olbrisch M, Azarbad L, Ryee M, Woodson M . Psychosocial evaluation of bariatric surgery candidates: a survey of present practices. Psychosom Med. 2005; 67(5):825-32. DOI: 10.1097/01.psy.0000174173.32271.01. View

16.

Ahmed A, Warton E, Schaefer C, Shen L, McIntyre R . The effect of bariatric surgery on psychiatric course among patients with bipolar disorder. Bipolar Disord. 2013; 15(7):753-63. PMC: 3844030. DOI: 10.1111/bdi.12109. View

17.

Nasrallah H, Meyer J, Goff D, McEvoy J, Davis S, Stroup T . Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res. 2006; 86(1-3):15-22. DOI: 10.1016/j.schres.2006.06.026. View

18.

Hamoui N, Kingsbury S, Anthone G, Crookes P . Surgical treatment of morbid obesity in schizophrenic patients. Obes Surg. 2004; 14(3):349-52. DOI: 10.1381/096089204322917873. View

19.

McKibbin C, Patterson T, Norman G, Patrick K, Jin H, Roesch S . A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res. 2006; 86(1-3):36-44. DOI: 10.1016/j.schres.2006.05.010. View

20.

Newcomer J, Hennekens C . Severe mental illness and risk of cardiovascular disease. JAMA. 2007; 298(15):1794-6. DOI: 10.1001/jama.298.15.1794. View